| Literature DB >> 29550678 |
Ying Feng1, Xikui Sun2, Xianmiao Ye3, Yupeng Feng3, Jinlin Wang3, Xuehua Zheng3, Xinglong Liu3, Changhua Yi3, Mingli Hao4, Qian Wang3, Feng Li5, Wei Xu5, Liang Li6, Chufang Li6, Rong Zhou6, Ling Chen7, Liqiang Feng8.
Abstract
Re-emerging human adenoviruses type 14 (HAdV14) and 55 (HAdV55) represent two highly virulent adenoviruses. The neutralizing antibody (nAb) responses elicited by infection or immunization remain largely unknown. Herein, we generated hexon-chimeric HAdV14 viruses harboring each single or entire hexon hyper-variable-regions (HVR) from HAdV55, and determined the neutralizing epitopes of human and mouse nAbs. In human sera, hexon-targeting nAbs are type-specific and mainly recognize HVR2, 5, and 7. Fiber-targeting nAbs are only detectable in sera cross-neutralizing HAdV14 and HAdV55 and contribute substantially to cross-neutralization. Penton-binding antibodies, however, show no significant neutralizing activities. In mice immunized with HAdV14 or HAdV55, a single immunization mainly elicited hexon-specific nAbs, which recognized HAdV14 HVR1, 2, and 7 and HAdV55 HVR1 and 2, respectively. After a booster immunization, cross-neutralizing fiber-specific nAbs became detectable. These results indicated that hexon elicits type-specific nAbs whereas fiber induces cross-neutralizing nAbs to HAdV14 and HAdV55, which are of significance in vaccine development.Entities:
Keywords: Epitopes; Human adenovirus type 14; Human adenovirus type 55; Neutralizing antibodies; Vaccine
Mesh:
Substances:
Year: 2018 PMID: 29550678 DOI: 10.1016/j.virol.2018.03.002
Source DB: PubMed Journal: Virology ISSN: 0042-6822 Impact factor: 3.616